Amphastar Pharmaceuticals, Inc 10-Q for FY2021 Q3
Amphastar Pharmaceuticals, Inc. (AMPH)
10-Q
2021-11-09
For: 2021-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Amphastar Pharmaceuticals, Inc filed this 10-Q on November 9, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).
Headline figures
Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $112.2M
- up 34.5% from $83.43M a year earlier
- Net income
- $29.55M
- up 654.0% from net income of $3.92M a year earlier
- Diluted EPS
- $0.59
- up 637.5% from $0.08 a year earlier